Lianyungang, China

Yong Gao

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong Gao. Retrieved from https://idiyas.com/inventor/yong-gao-pgjqkgv0

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yong Gao - Innovator in Pharmaceutical Chemistry

Introduction

Yong Gao is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development efforts.

Latest Patents

Yong Gao holds a patent for a pyrazole-substituted cyclopentanol ester derivative. This patent, which is represented by a specific chemical formula, relates to a compound that has potential applications in the pharmaceutical industry. The compound is characterized by its unique structure and is designed for use as a pharmaceutically acceptable salt.

Career Highlights

Gao is currently associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., where he continues to advance his research in drug development. His work has led to the creation of valuable compounds that may enhance therapeutic options in various medical fields.

Collaborations

Yong Gao has collaborated with esteemed colleagues such as Yinsheng Zhang and Bin Cao. These partnerships have fostered a productive research environment, enabling the exploration of innovative solutions in pharmaceutical applications.

Conclusion

Yong Gao's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a key figure in the industry. His ongoing work promises to impact the development of new therapeutic agents significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…